Atlas Trials

Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury

Clinical trial NCT06622239 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06622239
Sponsor
Seoul National University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nonsuicidal Self-Injury
Start date
2026-06-01
Primary completion
2027-02-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.